![Christina Coughlin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christina Coughlin
Vorstandsvorsitzender bei
AVACTA GROUP PLC
Vermögen: 87 471 $ am 31.05.2026
Profil
Christina Marie Coughlin currently works at Avacta Group Plc, as Chief Executive Officer & Executive Director from 2024.
Dr. Coughlin also formerly worked at Cytoimmune Therapeutics, Inc., as Chief Executive Officer & Director from 2021 to 2023, Rubius Therapeutics, Inc., as Chief Medical Officer from 2020 to 2021, Tmunity Therapeutics, Inc., as Chief Medical Officer from 2018 to 2019, and Immunocore Holdings Plc, as Chief Medical Officer from 2015 to 2018.
Dr. Coughlin received her doctorate degree from the University of Pennsylvania and undergraduate degree from Temple University (Pennsylvania).
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AVACTA GROUP PLC 0,02 % | 05.06.2026 | 82 142 ( 0,02 % ) | 87 471 $ | 31.05.2026 |
Aktive Positionen von Christina Coughlin
| Unternehmen | Position | Beginn |
|---|---|---|
| AVACTA GROUP PLC | Vorstandsvorsitzender | 01.04.2024 |
Ehemalige bekannte Positionen von Christina Coughlin
| Unternehmen | Position | Ende |
|---|---|---|
Cytoimmune Therapeutics, Inc.
 Cytoimmune Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes cancer immunotherapy products | Vorstandsvorsitzender | 18.07.2023 |
| RUBIUS THERAPEUTICS | Technik-/Wissenschafts-/F&E-Leiter | 12.11.2021 |
Tmunity Therapeutics, Inc.
 Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2019 |
| IMMUNOCORE HOLDINGS PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2018 |
Ausbildung von Christina Coughlin
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
12
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Temple University (Pennsylvania)
 Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avacta Group Plc
 Avacta Group Plc Miscellaneous Commercial ServicesCommercial Services Engages in the business of healthcare technology and consumables | Commercial Services |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Develops red cell therapeutics for cancer treatment | Health Technology |
Tmunity Therapeutics, Inc.
Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Immunocore Holdings Plc
 Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
Cytoimmune Therapeutics, Inc.
Cytoimmune Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes cancer immunotherapy products | Health Technology |
